ArticleMedical decision making : an international journal of the Society for Medical Decision Making2025
Health State Utility Values: The Implications of Patient versus Community Ratings in Assessing the Value of Care.
Article in Medical decision making : an international journal of the Society for Medical Decision Making, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
BackgroundHealth-state utility values (HSUVs) are key inputs into cost-utility analyses. There is debate over whether they are best derived from the community or patients, with concerns raised that community-derived preferences may devalue benefits to ill, elderly, or disabled individuals. This tutorial compares the effects of using patient-derived HSUVs versus community-derived HSUVs on incremental cost-effectiveness ratios (ICERs) and shows their implications for policy.DesignWe review published studies that compared HSUVs derived from patients and the community. We then present equations for the gains in quality-adjusted life-years (QALYs) that would be estimated for an intervention using patient versus community HSUVs and discuss the implications of those QALY gains. We present a numerical example as another way of showing how ICERs change when using patient versus community HSUVs.ResultsPatient HSUVs are generally higher than community HSUVs for severe health states. When an intervention reduces
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.